icon-    folder.gif   Conference Reports for NATAP  
 
  XIX International AIDS Conference
July 22-27, 2012
Washington, DC
Back grey_arrow_rt.gif
 
 
 
Analysis of Efficacy by Baseline HIV RNA - Week 48 Results from a Phase 3 Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF (Quad) Compared to Efavirenz/Emtricitabine/Tenofovir DF in Treatment Na•ve HIV-1 Infected Subjects
 
 
  Reported by Jules Levin
IAC July 22-27 2012 Wash DC
 
P Sax1, E DeJesus2, A Mills3, A Zolopa4, C Cohen5, D Wohl6, JE Gallant7, HC Liu8, L Zhong8, K Yale8, K White8, B Kearney8, J Szwarcberg8, E Quirk8, and A Cheng8 1Brigham and Women's Hospital, Harvard Medical School, Boston, MA, US; 2Orlando Immunology Center, Orlando, FL, US; 3Anthony Mills MD, Inc., Los Angeles, US; 4Stanford University, Palo Alto, CA, US; 5Community Research Initiative of New England, Boston, MA, US; 6University of North Carolina, Chapel Hill, NC, US; 7Johns Hopkins School of Medicine, Baltimore, MD, US; 8Gilead Sciences, Foster City, CA, US

IAC1.gif

IAC2.gif

IAC3.gif

IAC4.gif

IAC5.gif

IAC6.gif

IAC7.gif

IAC8.gif

IAC9.gif

IAC10.gif

IAC11.gif